Compared with MOC2OVA-Mock tumors, MOC2OVA-Sema6dOE tumors showed significantly faster growth and significantly decreased numbers of tumor-infiltrating CD8+ T cells and OVA-tetramer+ CD8+ T cells (Figure 4, B and C, and Supplemental Figure 6B). Here, CD8A is linked to neoplasm.